Literature DB >> 12670739

Arresting angiotensin type 1 receptors.

Walter G Thomas1, Hongwei Qian.   

Abstract

The type 1 angiotensin (AT(1)) receptor mediates the homeostatic and pathological actions of the peptide hormone, angiotensin II. With regard to the processes that activate and deactivate seven-transmembrane-spanning, G-protein-coupled receptors (GPCRs), AT(1) receptors are among the most widely studied, serving as prototypes for GPCRs that bind and respond to peptide hormones. Arrestins are proteins that bind to activated and phosphorylated GPCRs, terminating initial signals emanating from these receptors, in addition to mediating receptor internalization. New aspects of arrestin function continue to emerge, such as their capacity to act as scaffolds to recruit regulatory and signaling molecules to increase the repertoire of receptor responses. Here, we examine the evidence that arrestins contribute to the signaling, deactivation and trafficking of AT(1) receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670739     DOI: 10.1016/s1043-2760(03)00023-7

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  13 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

2.  Identification of Distinct Conformations of the Angiotensin-II Type 1 Receptor Associated with the Gq/11 Protein Pathway and the β-Arrestin Pathway Using Molecular Dynamics Simulations.

Authors:  Jérôme Cabana; Brian Holleran; Richard Leduc; Emanuel Escher; Gaétan Guillemette; Pierre Lavigne
Journal:  J Biol Chem       Date:  2015-05-01       Impact factor: 5.157

3.  Angiotensin II regulates neuronal excitability via phosphatidylinositol 4,5-bisphosphate-dependent modulation of Kv7 (M-type) K+ channels.

Authors:  Oleg Zaika; Lucienne S Lara; Nikita Gamper; Donald W Hilgemann; David B Jaffe; Mark S Shapiro
Journal:  J Physiol       Date:  2006-06-15       Impact factor: 5.182

Review 4.  Angiotensin II receptors and drug discovery in cardiovascular disease.

Authors:  Chiranjib Dasgupta; Lubo Zhang
Journal:  Drug Discov Today       Date:  2010-12-13       Impact factor: 7.851

Review 5.  Differential expression of microRNAs in ischemic heart disease.

Authors:  Minwoo A Song; Alexandra N Paradis; Maresha S Gay; John Shin; Lubo Zhang
Journal:  Drug Discov Today       Date:  2014-10-23       Impact factor: 7.851

Review 6.  Angiotensin II regulation of adrenocortical gene transcription.

Authors:  Edson F Nogueira; Wendy B Bollag; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2008-09-03       Impact factor: 4.102

7.  Angiotensin mediates renal fibrosis in the nephropathy of glycogen storage disease type Ia.

Authors:  W H Yiu; C-J Pan; R A Ruef; W-T Peng; M F Starost; B C Mansfield; J Y Chou
Journal:  Kidney Int       Date:  2007-12-12       Impact factor: 10.612

8.  Tissue-specific renin-angiotensin system in pulmonary lymphangioleiomyomatosis.

Authors:  Julio C Valencia; Gustavo Pacheco-Rodriguez; Adriana K Carmona; Janina Xavier; Patrick Bruneval; William K Riemenschneider; Yoshihiko Ikeda; Zu-Xi Yu; Victor J Ferrans; Joel Moss
Journal:  Am J Respir Cell Mol Biol       Date:  2006-02-10       Impact factor: 6.914

9.  Role of angiotensin II-induced rapid response genes in the regulation of enzymes needed for aldosterone synthesis.

Authors:  Edson F Nogueira; Yewei Xing; Claudia A V Morris; William E Rainey
Journal:  J Mol Endocrinol       Date:  2009-01-21       Impact factor: 5.098

10.  RNA sequencing to determine the contribution of kinase receptor transactivation to G protein coupled receptor signalling in vascular smooth muscle cells.

Authors:  Danielle Kamato; Venkata Vijayanand Bhaskarala; Nitin Mantri; Tae Gyu Oh; Dora Ling; Reearna Janke; Wenhua Zheng; Peter J Little; Narin Osman
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.